نتایج جستجو برای: paraproteinemia scleromyxedema systemic sclerosis

تعداد نتایج: 231334  

Journal: :Annals of the rheumatic diseases 1992
D O'Reilly L Taylor K el-Hadidy M I Jayson

Using computed thermography continuous temperature recordings were made before and after cold challenge of the fingers of control subjects and patients with primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis. Basal skin temperature measurements (Tpre) were significantly lower in patients with primary Raynaud's phenomenon and Raynaud's phenomenon associated ...

2017
Bumsoo Park Raghavendra C Vemulapalli Amit Gupta Maria E Shreve Della A Rees

Systemic sclerosis, or scleroderma, is a complex medical disorder characterized by limited or diffuse skin thickening with frequent involvement of internal organs such as lungs, gastrointestinal tract, or kidneys. Docetaxel is a chemotherapeutic agent which has been associated with cutaneous side effects. An uncommon cutaneous side effect of docetaxel is scleroderma-like skin changes that exten...

Journal: :Acta pharmaceutica 2005
Filip Spirovski Kiro Stojanoski Angel Mitrevski

Standard electrophoresis methods were used in the qualitative and quantitative protein analyses of cerebrospinal fluid (CSF). Disc electrophoresis was carried out for detection of oligoclonal IgG bands in cerebrospinal fluid on polyacrylamide gel. Pairs of CSF and serum were taken from 30 patients, mainly with multiple sclerosis and other central nervous system dysfunctions, polyradiculoneuriti...

Journal: :Sovremennaâ Revmatologiâ 2023

A clinical case of the development rapidly progressive systemic sclerosis after repeated coronavirus infection is described. The contribution occupational hazards, oncological process and radiation therapy to pathogenesis this disease discussed. Hydropericardium was a feature picture, as well rare immunological markers late onset sclerosis.

Journal: :The Lancet Rheumatology 2021

Recent approval of the anti-interleukin (IL)-6 receptor antibody tocilizumab by US Food and Drug Administration (FDA) for slowing rate decline in pulmonary function adult patients with systemic sclerosis-associated interstitial lung disease is a welcome step towards better treatment outcomes sclerosis. Systemic has emerged as one major causes death very high burden unmet need. Tocilizumab secon...

Journal: :Ear, Nose & Throat Journal 2013

Journal: :Current Opinion in Rheumatology 2015

Journal: :Rheumatology Research 2017

Journal: : 2021

To evaluate the effect of intravenous rituximab, a monoclonal antibody to B-cells, on interstitial lung disease, skin fibrosis and arthritis in patients with systemic sclerosis (SSc).

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید